Niacin

Pellagra, Hardening of the Arteries, dietary supplementation + 14 more

Treatment

8 FDA approvals

20 Active Studies for Niacin

What is Niacin

Niacin

The Generic name of this drug

Treatment Summary

Niacin is a B vitamin used to treat vitamin deficiencies as well as hyperlipidemia, dyslipidemia, hypertriglyceridemia, and to reduce the risk of myocardial infarctions.[L7550,L7553,L7556,L7559,L7562,L7565]

O-Cal FA multivitamin

is the brand name

image of different drug pills on a surface

Niacin Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

O-Cal FA multivitamin

Niacin

1970

106

Approved as Treatment by the FDA

Niacin, also known as O-Cal FA multivitamin, is approved by the FDA for 8 uses which include High Cardiovascular Risk and Hyperlipidemia .

High Cardiovascular Risk

Used in combination with other therapies

Hyperlipidemia

Used in combination with Sevelamer to help manage Hyperlipidemias

Hardening of the Arteries

Used in combination with Sevelamer to help manage Atherosclerosis

High Cholesterol

Used in combination with Sevelamer to help manage Hyperlipidemias

Coronary Artery Disease

Used in combination with Sevelamer to help manage history of coronary artery disease

dietary supplementation

Used in combination with Niacin for dietary supplementation

Primary Hypercholesterolemia

Used in combination with other therapies

Dietary Modifications

Used in combination with other therapies

When to interrupt dosage

The proposed portion of Niacin is contingent upon the diagnosed state. The measure of dosage fluctuates, depending on the technique of delivery as displayed in the table beneath.

Condition

Dosage

Administration

Dietary Modifications

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet - Oral, Capsule - Oral, Capsule, Liquid - Oral, Liquid, Tablet, Topical, Shampoo, Shampoo - Topical, Tablet, extended release - Oral, Capsule, liquid filled, Tablet, extended release, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Capsule, extended release, Powder - Oral, Powder, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Solution / drops - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule, liquid filled - Oral, Solution, Kit - Oral, Kit, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral

Coronary Artery Disease

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet - Oral, Capsule - Oral, Capsule, Liquid - Oral, Liquid, Tablet, Topical, Shampoo, Shampoo - Topical, Tablet, extended release - Oral, Capsule, liquid filled, Tablet, extended release, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Capsule, extended release, Powder - Oral, Powder, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Solution / drops - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule, liquid filled - Oral, Solution, Kit - Oral, Kit, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral

Risk of pancreatitis

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet - Oral, Capsule - Oral, Capsule, Liquid - Oral, Liquid, Tablet, Topical, Shampoo, Shampoo - Topical, Tablet, extended release - Oral, Capsule, liquid filled, Tablet, extended release, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Capsule, extended release, Powder - Oral, Powder, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Solution / drops - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule, liquid filled - Oral, Solution, Kit - Oral, Kit, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral

Combined Modality Therapy

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet - Oral, Capsule - Oral, Capsule, Liquid - Oral, Liquid, Tablet, Topical, Shampoo, Shampoo - Topical, Tablet, extended release - Oral, Capsule, liquid filled, Tablet, extended release, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Capsule, extended release, Powder - Oral, Powder, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Solution / drops - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule, liquid filled - Oral, Solution, Kit - Oral, Kit, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral

inadequate response to diet

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet - Oral, Capsule - Oral, Capsule, Liquid - Oral, Liquid, Tablet, Topical, Shampoo, Shampoo - Topical, Tablet, extended release - Oral, Capsule, liquid filled, Tablet, extended release, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Capsule, extended release, Powder - Oral, Powder, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Solution / drops - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule, liquid filled - Oral, Solution, Kit - Oral, Kit, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral

Hypertriglyceridemia

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet - Oral, Capsule - Oral, Capsule, Liquid - Oral, Liquid, Tablet, Topical, Shampoo, Shampoo - Topical, Tablet, extended release - Oral, Capsule, liquid filled, Tablet, extended release, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Capsule, extended release, Powder - Oral, Powder, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Solution / drops - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule, liquid filled - Oral, Solution, Kit - Oral, Kit, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral

High Cholesterol

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet - Oral, Capsule - Oral, Capsule, Liquid - Oral, Liquid, Tablet, Topical, Shampoo, Shampoo - Topical, Tablet, extended release - Oral, Capsule, liquid filled, Tablet, extended release, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Capsule, extended release, Powder - Oral, Powder, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Solution / drops - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule, liquid filled - Oral, Solution, Kit - Oral, Kit, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral

Hardening of the Arteries

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet - Oral, Capsule - Oral, Capsule, Liquid - Oral, Liquid, Tablet, Topical, Shampoo, Shampoo - Topical, Tablet, extended release - Oral, Capsule, liquid filled, Tablet, extended release, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Capsule, extended release, Powder - Oral, Powder, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Solution / drops - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule, liquid filled - Oral, Solution, Kit - Oral, Kit, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral

dietary supplementation

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet - Oral, Capsule - Oral, Capsule, Liquid - Oral, Liquid, Tablet, Topical, Shampoo, Shampoo - Topical, Tablet, extended release - Oral, Capsule, liquid filled, Tablet, extended release, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Capsule, extended release, Powder - Oral, Powder, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Solution / drops - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule, liquid filled - Oral, Solution, Kit - Oral, Kit, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral

Primary Hypercholesterolemia

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet - Oral, Capsule - Oral, Capsule, Liquid - Oral, Liquid, Tablet, Topical, Shampoo, Shampoo - Topical, Tablet, extended release - Oral, Capsule, liquid filled, Tablet, extended release, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Capsule, extended release, Powder - Oral, Powder, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Solution / drops - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule, liquid filled - Oral, Solution, Kit - Oral, Kit, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral

cholesterol

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet - Oral, Capsule - Oral, Capsule, Liquid - Oral, Liquid, Tablet, Topical, Shampoo, Shampoo - Topical, Tablet, extended release - Oral, Capsule, liquid filled, Tablet, extended release, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Capsule, extended release, Powder - Oral, Powder, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Solution / drops - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule, liquid filled - Oral, Solution, Kit - Oral, Kit, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral

Myocardial Infarction

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet - Oral, Capsule - Oral, Capsule, Liquid - Oral, Liquid, Tablet, Topical, Shampoo, Shampoo - Topical, Tablet, extended release - Oral, Capsule, liquid filled, Tablet, extended release, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Capsule, extended release, Powder - Oral, Powder, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Solution / drops - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule, liquid filled - Oral, Solution, Kit - Oral, Kit, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral

Hyperlipidemias

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet - Oral, Capsule - Oral, Capsule, Liquid - Oral, Liquid, Tablet, Topical, Shampoo, Shampoo - Topical, Tablet, extended release - Oral, Capsule, liquid filled, Tablet, extended release, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Capsule, extended release, Powder - Oral, Powder, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Solution / drops - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule, liquid filled - Oral, Solution, Kit - Oral, Kit, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral

Triglycerides

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet - Oral, Capsule - Oral, Capsule, Liquid - Oral, Liquid, Tablet, Topical, Shampoo, Shampoo - Topical, Tablet, extended release - Oral, Capsule, liquid filled, Tablet, extended release, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Capsule, extended release, Powder - Oral, Powder, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Solution / drops - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule, liquid filled - Oral, Solution, Kit - Oral, Kit, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral

Dyslipidemias

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet - Oral, Capsule - Oral, Capsule, Liquid - Oral, Liquid, Tablet, Topical, Shampoo, Shampoo - Topical, Tablet, extended release - Oral, Capsule, liquid filled, Tablet, extended release, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Capsule, extended release, Powder - Oral, Powder, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Solution / drops - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule, liquid filled - Oral, Solution, Kit - Oral, Kit, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral

Pellagra

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet - Oral, Capsule - Oral, Capsule, Liquid - Oral, Liquid, Tablet, Topical, Shampoo, Shampoo - Topical, Tablet, extended release - Oral, Capsule, liquid filled, Tablet, extended release, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Capsule, extended release, Powder - Oral, Powder, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Solution / drops - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule, liquid filled - Oral, Solution, Kit - Oral, Kit, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral

High Cardiovascular Risk

, 500.0 mg, 750.0 mg, 1000.0 mg, 15.0 mg, 12.2 mg/mL, 10.0 mg, 0.02 mg/mL, 3.0 mg, 20.0 mg, 6.0 mg, 100.0 mg, 475.0 mg, 50.0 mg, 300.0 mg, 400.0 mg, 30.0 mg, 250.0 mg, 12.5 mg, 8.3 mg, 6.6 mg, 11.5 mg, 13.5 mg, 25.0 mg, 8.0 mg/mL, 0.2 mg, 125.0 mg, 375.0 mg, 0.15 mg, 5.0 mg, 2.5 mg, 17.0 mg, 0.5 mg, 1.8 mg, 1.5 mg, 18.0 mg, 200.0 mg, 0.33 mg, 19.0 mg, 75.0 mg, 0.55 mg, 60.0 mg, 17.5 mg, 3.34 mg, 22.5 mg, 6.25 mg, 1.0 mg, 1.66 mg, 7.0 mg, 3.75 mg, 8.0 mg, 12.0 mg, 16.7 mg, 6.67 mg, 7.5 mg, 35.0 mg, 45.0 mg, 40.0 mg, 3.3 mg, 52.0 mg, 2.0 mg, 0.018 mg/mg, 0.13 mg/mL, 15.0 mg/mL, 18.0 mg/mL, 0.2 mg/mL, 10.0 mg/mL, 0.002 mg/mg, 14.5 mg/mL, 30.0 mg/mL, 100.0 mg/mL, 800.0 mg/mL

, Tablet, film coated, extended release, Oral, Tablet, film coated, extended release - Oral, Tablet - Oral, Capsule - Oral, Capsule, Liquid - Oral, Liquid, Tablet, Topical, Shampoo, Shampoo - Topical, Tablet, extended release - Oral, Capsule, liquid filled, Tablet, extended release, Intramuscular; Intravenous, Solution - Intramuscular; Intravenous, Capsule, extended release, Powder - Oral, Powder, Capsule, extended release - Oral, Lozenge - Oral, Lozenge, Tablet, extended release; Tablet, multilayer, extended release, Tablet, extended release; Tablet, multilayer, extended release - Oral, Solution / drops, Solution / drops - Oral, Tablet, chewable, Tablet, chewable - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, Delayed Release - Oral, Solution - Oral, Tablet, Delayed Release, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule, liquid filled - Oral, Solution, Kit - Oral, Kit, Tablet, coated - Oral, Tablet, coated, Tablet, film coated, Tablet, film coated - Oral

Warnings

Niacin Contraindications

Condition

Risk Level

Notes

Hypervitaminosis

Do Not Combine

Liver Dysfunction

Do Not Combine

Transaminases

Do Not Combine

Hemorrhage

Do Not Combine

Liver Diseases

Do Not Combine

Peptic Ulcer

Do Not Combine

Transaminases

Do Not Combine

There are 20 known major drug interactions with Niacin.

Common Niacin Drug Interactions

Drug Name

Risk Level

Description

Abemaciclib

Major

The metabolism of Abemaciclib can be decreased when combined with Niacin.

Acalabrutinib

Major

The metabolism of Acalabrutinib can be decreased when combined with Niacin.

Acenocoumarol

Major

The metabolism of Acenocoumarol can be decreased when combined with Niacin.

Alectinib

Major

The metabolism of Alectinib can be decreased when combined with Niacin.

Alpelisib

Major

The metabolism of Alpelisib can be decreased when combined with Niacin.

image of a doctor in a lab doing drug, clinical research

Niacin Novel Uses: Which Conditions Have a Clinical Trial Featuring Niacin?

Currently, there are no active trials assessing the potential of Niacin in treating undefined conditions.

Condition

Clinical Trials

Trial Phases

Coronary Artery Disease

0 Actively Recruiting

dietary supplementation

1 Actively Recruiting

Not Applicable

High Cholesterol

17 Actively Recruiting

Phase 2, Phase 3, Early Phase 1, Not Applicable

Dyslipidemias

1 Actively Recruiting

Phase 2

Pellagra

0 Actively Recruiting

cholesterol

4 Actively Recruiting

Phase 3, Not Applicable

Hyperlipidemias

0 Actively Recruiting

Risk of pancreatitis

0 Actively Recruiting

Hardening of the Arteries

17 Actively Recruiting

Not Applicable, Phase 4, Phase 2, Phase 3

Primary Hypercholesterolemia

8 Actively Recruiting

Phase 2, Phase 3, Not Applicable

Combined Modality Therapy

0 Actively Recruiting

High Cardiovascular Risk

1 Actively Recruiting

Phase 3

Dietary Modifications

2 Actively Recruiting

Early Phase 1, Not Applicable

Triglycerides

0 Actively Recruiting

Hypertriglyceridemia

5 Actively Recruiting

Phase 3, Phase 2

Myocardial Infarction

0 Actively Recruiting

inadequate response to diet

0 Actively Recruiting

Niacin Reviews: What are patients saying about Niacin?

5

Patient Review

1/19/2010

Niacin for Combined High Blood Cholesterol and Triglyceride Level

I've been taking 500mg of niacin for the past eight months, and it has helped me lower my triglyceride levels significantly. I'm also on 80mg of lipitor for my cholesterol, which is now under control. Thanks to a combination of these medicines, diet, and exercise, I'm feeling much better.

4.7

Patient Review

10/18/2009

Niacin for Deficiency of the Vitamin Niacin

I've only been on this medication for a week, but I already feel groggy in the morning. Additionally, it seems like my blood pressure has gone up (I experience ringing in my ears now). The upside is that this is the best cholesterol medication I can take without getting flu-like symptoms, so I'll have to see if I can get used to the side effects.

4.7

Patient Review

7/16/2014

Niacin for Combined High Blood Cholesterol and Triglyceride Level

I sometimes experience redness in my face after taking this medication, but it goes away relatively quickly.

4.3

Patient Review

2/20/2011

Niacin for Combined High Blood Cholesterol and Triglyceride Level

I saw a significant increase in my HDL from 39 to 49 in just six months. That said, I do have quite severe reactions to the niacin about once a week. They usually manifest as rashes and extreme itchiness, lasting around 45 minutes. My doctor has me taking 1000mg twice daily.

4

Patient Review

8/4/2009

Niacin for High Amount of Triglyceride in the Blood

3.7

Patient Review

1/23/2010

Niacin for Increased Triglycerides and Cholesterol

I had a very unpleasant experience with this medication. I woke up in the middle of the night feeling like my skin was on fire, and shortly after lost consciousness due to low blood pressure. Needless to say, I won't be trying cholesterol management medication again.

3.7

Patient Review

9/16/2010

Niacin for Low HDL Cholesterol

Unfortunately, this medication made me nauseous and I would vomit not long after taking it.

3.3

Patient Review

3/29/2010

Niacin for Low HDL Cholesterol

I took this for three years before I started to experience liver damage. You have to get regular blood tests if you want to take this medication safely.

2.7

Patient Review

8/1/2009

Niacin for Combined High Blood Cholesterol and Triglyceride Level

2.3

Patient Review

2/22/2010

Niacin for High Cholesterol

I've only been on this for a couple weeks, as per my doctor's orders. I'm supposed to increase the dosage in a few months. So far I haven't experienced any negative side effects, which is great. And although it's early, I'm already feeling better.

2.3

Patient Review

7/12/2016

Niacin for Combined High Blood Cholesterol and Triglyceride Level

I was originally paralyzed at age 12 due to a neurological syndrome, but I recovered 90% of my body. However, when I started taking niacin for cholesterol under my doctor's supervision at 48 years old, I quickly began experiencing severe leg weakness again.

2.3

Patient Review

2/27/2021

Niacin for Increased Triglycerides and Cholesterol

I had to discontinue this after my blood sugar spiked. Thankfully, it returned to normal levels on its own.

1.3

Patient Review

9/27/2009

Niacin for High Cholesterol

1

Patient Review

4/19/2010

Niacin for Low HDL Cholesterol

I started taking Niacin 500 mg per day as recommended by my doctor to help with Hypothyroidism, but within 10 minutes of taking it I felt really uncomfortable. My skin would itch and turn bright red, and I just didn't like the way it made me feel overall.

1

Patient Review

2/2/2013

Niacin for High Amount of Triglyceride in the Blood

I've only been on this medication for a short time, but I have already experienced some stomach discomfort. I take it after supper instead of before bedtime so that my food can help absorb the pill and avoid further irritation.

1

Patient Review

8/29/2014

Niacin for Slow Progression of Disease of the Arteries of the Heart

After 15 years of using "advicor," I had a heart attack due to seven blockages. I needed a quadruple bypass as a result. I'm only 64, relatively fit, and have no other health concerns. This drug is incredibly dangerous and should be removed from the market immediately.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about niacin

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is niacin harmful to the body?

"Niacin can have some serious side effects, including liver problems, stomach ulcers, changes in blood sugar levels, muscle damage, low blood pressure, and heart rhythm changes."

Answered by AI

Which foods contain niacin?

"There are many foods rich in niacin. Animal products such as meat, fish and poultry are high in niacin. Vegetarian sources of niacin include avocado, peanuts, whole grains, mushrooms, green peas and potatoes."

Answered by AI

Is B12 and niacin the same thing?

"There are eight B vitamins in total, including B3 (niacin). They can be found naturally in meat, poultry, fish, eggs, and green vegetables."

Answered by AI

What does niacin do for the body?

"Niacin, or vitamin B3, is an important nutrient that is necessary for every part of your body to function properly. Niacin supplements may help lower cholesterol, ease arthritis, and boost brain function, but they can also cause serious side effects if taken in large doses."

Answered by AI

Clinical Trials for Niacin

Image of University of Alberta in Edmonton, Canada.

Pharmacist-led Care for Diabetes

18+
All Sexes
Edmonton, Canada

As of 2024, nine percent of Albertans are living with Type 2 diabetes, which increases their risk for cardiovascular disease, stroke, blindness, and kidney failure. Unfortunately, less than half of patients have controlled Type 2 diabetes. We are well aware of the factors which lead to worsening diabetes, but need to give people more support to help them manage their diabetes. Pharmacists are respected health care professionals who are often easier to see that doctors and can help people with diabetes to stay as healthy as possible. This research project aims to see whether a pharmacist service can help improve diabetes management in people with type 2 diabetes compared to usual care from their family physician or nurse practitionner. The potential impact of this project is to empower people with type 2 diabetes to understand their condition, it's management, and to achieve target blood sugar levels, which will ultimately reduce the risk of diabetes-related complications.

Recruiting
Has No Placebo

University of Alberta

Ross Tsuyuki, BScPharm, PharmD, MSc

Have you considered Niacin clinical trials?

We made a collection of clinical trials featuring Niacin, we think they might fit your search criteria.
Go to Trials
Image of Lipid Clinic at Brown University Health in Providence, United States.

2-HOBA Supplementation for High Cholesterol

18 - 69
All Sexes
Providence, RI

The goal of this clinical trial is to learn if a natural supplement called 2-hydroxybenzylamine (2-HOBA) can reduce harmful oxidized lipids and improve the function of lipoprotein(a) in adults with high lipoprotein(a) levels. The main questions it aims to answer are: Does 2-HOBA lower oxidized phospholipids on lipoprotein(a)? Does 2-HOBA reduce markers of inflammation and blood clotting in the blood? Participants will: Take 2-HOBA capsules (400 mg, three times daily with meals) for 6 weeks Provide blood and urine samples at the beginning, middle, and end of the study Have lab tests to measure changes in lipids, inflammation, and clotting markers

Waitlist Available
Has No Placebo

Lipid Clinic at Brown University Health

Wenliang Song, MD

Have you considered Niacin clinical trials?

We made a collection of clinical trials featuring Niacin, we think they might fit your search criteria.
Go to Trials
Image of Sidney & Lois Eskenazi Hospital in Indianapolis, United States.

Composite Intervention for Metabolic Syndrome

18+
All Sexes
Indianapolis, IN

The objective of this study is to pilot a multifaceted, optimized intervention for metabolic syndrome (MetS) in emergency department patients to establish feasibility. Participants (n=20) will be randomized to intervention or control (usual care). The composite intervention will include an educational video outlining the adverse effects of MetS and the benefit of walking, a written exercise prescription with a defined goal of walking 150 minutes per week, a Fitbit accelerometer device, resources for healthy eating practices, periodic text message reminders, and an urgent referral to primary care and our health system's Healthy Me clinic for follow-up visit. Investigators hypothesize that this approach will change patient understanding and motivation to increase physical activity and healthy eating habits.

Recruiting
Has No Placebo

Sidney & Lois Eskenazi Hospital

Image of Duke University Medical Center in Durham, United States.

Cardiometabolic Prevention Clinic for Cardiovascular Disease

18+
All Sexes
Durham, NC

This project is studying whether a team-based specialty clinic can help people with type 2 diabetes and heart disease better manage their blood pressure and cholesterol. The clinic includes coordinated care from heart doctors, kidney doctors, diabetes specialists, and liver doctors. The study will compare two groups of patients: one receiving usual care from their primary care provider, and one referred to the Duke Cardiometabolic Prevention Clinic for multidisciplinary care. The main goals are to find out if this clinic improves blood pressure and cholesterol control over 12 months, increases use of recommended heart medications, and reduces hospital visits and other healthcare use. Participants will be randomly assigned to one of the two groups. Those referred to the clinic will: 1) Meet with a cardiologist for an initial evaluation. 2) Be referred to other specialists (such as endocrinology, nephrology, or hepatology) based on their needs. 3) Receive ongoing, coordinated care from a team of specialists working together to improve their heart and metabolic health.

Recruiting
Has No Placebo

Duke University Medical Center

Neha J Pagidipati, MD, MPH

Image of University of Alabama at Birmingham in Birmingham, United States.

Inspire HER for Cardiovascular Disease

30 - 79
Female
Birmingham, AL

Poor heart health puts Black women at risk for a shorter life with more illness than people of any other non-indigenous racial group. We will refine and conduct a randomized, wait-list controlled trial of Inspire HER (a heart health lifestyle intervention for Black women that provides health education, physical activity, and social resources). We will also compare Inspire HER and Black Impact (a heart health intervention for Black men) data to study how women and men respond differently to stress. This trial aligns with American Heart Association's pledge to address heart health equity through new interventions that consider the person and the circumstances with which they live.

Recruiting
Has No Placebo

University of Alabama at Birmingham

Timiya S Nolan, PhD

Image of Rush University Medical Center in Chicago, United States.

Health Coaching for Heart Disease

40 - 75
All Sexes
Chicago, IL

The goal of this longitudinal study is to investigate the role of virtual health coaching on mitigation of cardiometabolic disease risk in an underserved, food insecure population. The main questions it aims to answer are: * Does longitudinal, individualized health coaching directed at lifestyle modification reduce patient 10-year risk of heart attack or stroke? * Does longitudinal, individualized health coaching directed at lifestyle modification reduce rates of hypertension, hyperlipidemia, and diabetes? * Does longitudinal, individualized health coaching directed at lifestyle modification improve accessibility to healthcare? Researchers will investigate the effects of regularly scheduled health coaching sessions on composite cardiometabolic risk profile as well as individual modifiable cardiovascular risk factors. Participants will: * Participate in in-person cardiovascular screening, occuring at the time of enrollment, months 3 and 6. * Engage in virtual health coaching sessions to talk about diet, exercise, weight loss, blood pressure and diabetes control, and accessibility to healthcare * Keep a log of their blood pressure

Waitlist Available
Has No Placebo

Rush University Medical Center

Daniel Luger, MD

Have you considered Niacin clinical trials?

We made a collection of clinical trials featuring Niacin, we think they might fit your search criteria.
Go to Trials